Headache and psychological variables as predictors of disability in individuals with primary headache disorders.
anxiety
depression
disability
fear of pain
headache
migraine
Journal
Headache
ISSN: 1526-4610
Titre abrégé: Headache
Pays: United States
ID NLM: 2985091R
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
revised:
08
08
2023
received:
10
05
2023
accepted:
10
08
2023
medline:
1
11
2023
pubmed:
5
10
2023
entrez:
5
10
2023
Statut:
ppublish
Résumé
To examine the relative contribution of headache symptoms and psychological factors to headache-related disability. Both headache symptoms and comorbid psychological factors (psychiatric symptoms and transdiagnostic constructs) negatively impact functioning among individuals with migraine and tension-type headache, but few studies have explored their relative contribution to headache-related disability. We hypothesized that psychiatric symptoms and transdiagnostic variables would afford incremental contribution to disability beyond headache symptoms, and we investigated the moderating role of headache diagnosis on these relationships. This cross-sectional study examined data from a southern U.S. university online sample of 1818 young adults (mean [SD] age 19.0 [5.1] years; 74.6% female) who met the International Classification of Headache Disorders, third edition criteria for primary headache disorders (46.6% episodic migraine, 11.6% chronic migraine, 38.3% episodic tension-type headache, 3.5% chronic tension-type headache) and completed measures assessing psychological factors and headache-related disability. Headache, psychiatric symptoms, and transdiagnostic factors were examined in relation to headache-related disability, after controlling for sex. Moderation analyses examined the conditional effect of diagnosis on disability. As predicted, both psychiatric and transdiagnostic symptoms accounted for unique variance in headache-related disability beyond headache symptoms (R Psychiatric and transdiagnostic factors contribute uniquely to headache-related functional impairment, which may be important for expanding targeted assessment and behavioral interventions.
Sections du résumé
OBJECTIVE
To examine the relative contribution of headache symptoms and psychological factors to headache-related disability.
BACKGROUND
Both headache symptoms and comorbid psychological factors (psychiatric symptoms and transdiagnostic constructs) negatively impact functioning among individuals with migraine and tension-type headache, but few studies have explored their relative contribution to headache-related disability. We hypothesized that psychiatric symptoms and transdiagnostic variables would afford incremental contribution to disability beyond headache symptoms, and we investigated the moderating role of headache diagnosis on these relationships.
METHODS
This cross-sectional study examined data from a southern U.S. university online sample of 1818 young adults (mean [SD] age 19.0 [5.1] years; 74.6% female) who met the International Classification of Headache Disorders, third edition criteria for primary headache disorders (46.6% episodic migraine, 11.6% chronic migraine, 38.3% episodic tension-type headache, 3.5% chronic tension-type headache) and completed measures assessing psychological factors and headache-related disability. Headache, psychiatric symptoms, and transdiagnostic factors were examined in relation to headache-related disability, after controlling for sex. Moderation analyses examined the conditional effect of diagnosis on disability.
RESULTS
As predicted, both psychiatric and transdiagnostic symptoms accounted for unique variance in headache-related disability beyond headache symptoms (R
CONCLUSION
Psychiatric and transdiagnostic factors contribute uniquely to headache-related functional impairment, which may be important for expanding targeted assessment and behavioral interventions.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1259-1270Informations de copyright
© 2023 American Headache Society.
Références
Global Burden of Disease Study 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954-976.
Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z. Migraine remains second among the world's causes of disability, and first among young women: findings from GBD 2019. J Headache Pain. 2020;21(1):1-4.
Bonafede M, Sapra S, Shah N, Tepper S, Cappell K, Desai P. Direct and indirect healthcare resource utilization and costs among migraine patients in the United States. Headache. 2018;58:700-714.
Burton WN, Landy SH, Downs KE, Runken MC. The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research. Mayo Clin Proc. 2009;84:436-445.
Hawkins K, Wang S, Rupnow M. Direct cost burden among insured US employees with migraine. Headache. 2008;48:553-563.
Lenaerts ME. Burden of tension-type headache. Curr Pain Headache Rep. 2006;10:459-462.
Pop PHM, Gierveld CM, Karis HAM, Tiedink HGM. Epidemiological aspects of headache in a workplace setting and the impact on the economic loss. Eur J Neurol. 2002;9:171-174.
Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53:427-436.
Rogers DG, Protti TA, Smitherman TA. Fear, avoidance, and disability in headache disorders. Curr Pain Headache Rep. 2020;24:33.
Burch RC, Buse DC, Lipton RB. Migraine: epidemiology, burden, and comorbidity. Neurol Clin. 2019;37(4):631-649.
Ford S, Calhoun A, Kahn K, Mann J, Finkel A. Predictors of disability in migraineurs referred to a tertiary clinic: neck pain, headache characteristics, and coping behaviors. Headache. 2008;48(4):523-528.
Tkachuk GA, Cottrell CK, Gibson JS, O'Donnell FJ, Holroyd KA. Factors associated with migraine-related quality of life and disability in adolescents: a preliminary investigation. Headache. 2003;43(9):950-955.
Kim B, Chung C, Chu MK, Chung YK, Lee C, Kim J. Factors associated with disability and impact of tension-type headache: findings of the Korean headache survey. J Headache Pain. 2015;16(1):1-8.
Lipton RB, Seng EK, Chu MK, et al. The effect of psychiatric comorbidities on headache-related disability in migraine: results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study. Headache. 2020;60:1683-1696.
Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalalgia. 2005;25(3):165-178.
Peck KR, Roland MM, Smitherman TA. Factors associated with medication-overuse headache in patients seeking treatment for primary headache. Headache. 2018;58(5):648-660.
Heckman BD, Holroyd KA. Tension-type headache and psychiatric comorbidity. Curr Pain Headache Rep. 2006;10(6):439-447.
Saunders K, Merikangas K, Low NCP, Von Korff M, Kessler RC. Impact of comorbidity on headache-related disability. Neurology. 2008;70(7):538-547.
Walters-Pellegrino AB, Davis-Martin RE, Houle TT, Turner DP, Smitherman TA. Perceived triggers of primary headache disorders: a meta-analysis. Cephalalgia. 2018;38:1188-1198.
Polk AN, Protti TA, Smitherman TA. Allodynia and disability in migraine: the mediating role of stress. Headache. 2020;60(10):2281-2290.
Borsook D, Maleki N, Becerra L, McEwen B. Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load. Neuron. 2012;73(2):219-234.
Vlaeyen JWS, Linton SJ. Fear-avoidance model of chronic musculoskeletal pain: 12 years on. Pain. 2012;153(6):1144-1147.
Black AK, Fulwiler JC, Smitherman TA. The role of fear of pain in headache. Headache. 2015;55:669-679.
Ocanez KLS, McHugh RK, Otto MW. A meta-analytic review of the association between anxiety sensitivity and pain. Depress Anxiety. 2010;27:760-767.
Short NA, van Rooij SJH, Murty VP, et al. Anxiety sensitivity as a transdiagnostic risk factor for trajectories of adverse posttraumatic neuropsychiatric sequelae in the AURORA study. J Psychiatr Res. 2022;156:45-54.
Farris SG, Burr EK, Abrantes AM, et al. Anxiety sensitivity as a risk indicator for anxiety, depression, and headache severity in women with migraine. Headache. 2019;59(8):1212-1220.
Smitherman TA, Davis RE, Walters AB, Young J, Houle TT. Anxiety sensitivity and headache: diagnostic differences, impact, and relations with perceived headache triggers. Cephalalgia. 2015;35(8):710-721.
Thaxter LY, Smitherman TA. The effect of the COVID-19 pandemic on headache-related disability among young adults with migraine. Headache. 2022;62(10):1293-1301.
Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.
Rains J, Penzien D, Lipchik G, Ramadan N. Diagnosis of migraine: empirical analysis of a large clinical sample of atypical migraine (IHS 1.7) patients and proposed revision of the IHS criteria. Cephalalgia. 2001;21(5):584-595.
Meade AW, Craig SB. Identifying careless responses in survey data. Psychol Methods. 2012;17(3):437-455.
Smitherman TA, Penzien DB, Rains JC, Nicholson RA, Houle TT. Headache. Hogrefe Publishing; 2015.
Andrew ME, Penzien DB, Rains JC, Knowlton GE, McAnulty RD. Development of a computer application for headache diagnosis: the headache diagnostic system. Int J Biomed Comput. 1992;31(1):17-24.
Kosinski M, Bayliss MS, Bjorner JB, et al. A six-item short-form survey for measuring headache impact: the HIT-6™. Qual Life Res. 2003;12(8):963-974.
Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck depression and anxiety inventories. Behav Res Ther. 1995;33:335-343.
Antony MM, Bieling PJ, Cox BJ, Enns MW, Swinson RP. Psychometric properties of the 42-item and 21-item versions of the depression anxiety stress scales in clinical groups and a community sample. Psychol Assess. 1998;10(2):176-181.
Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol. 2005;44(2):227-239.
McCracken LM, Dhingra L. A short version of the Pain Anxiety Symptoms Scale (PASS-20): preliminary development and validity. Pain Res Manag. 2002;7(1):45-50.
McCracken LM, Zayfert C, Gross RT. The pain anxiety symptoms scale: development and validation of a scale to measure fear of pain. Pain. 1992;50:67-73.
Taylor S, Zvolensky MJ, Cox BJ, et al. Robust dimensions of anxiety sensitivity: development and initial validation of the anxiety sensitivity index-3. Psychol Assess. 2007;19(2):176-188.
Hayes AF. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. Guilford Publications; 2017.
Bardel A, Wallander M, Wallman T, et al. Age and sex related self-reported symptoms in a general population across 30 years: patterns of reporting and secular trend. PLoS ONE. 2019;14:e0211532.
Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343-349.
Affatato O, Moulin TC, Pisanu C, et al. High efficacy of onabotulinumtoxinA treatment in patients with comorbid migraine and depression: a meta-analysis. J Transl Med. 2021;19:1-11.
Lipton RB, Cohen JM, Galic M, et al. Effects of fremanezumab in patients with chronic migraine and comorbid depression: subgroup analysis of the randomized HALO CM study. Headache. 2021;61(4):662-672.
Seng EK, Holroyd KA. Psychiatric comorbidity and response to preventative therapy in the treatment of severe migraine trial. Cephalalgia. 2012;32(5):390-400.
Smitherman TA, Tietjen GE, Schuh K, et al. Efficacy of galcanezumab for migraine prevention in patients with a medical history of anxiety and/or depression: a post hoc analysis of the phase 3, randomized, double-blind, placebo-controlled REGAIN, and pooled EVOLVE-1 and EVOLVE-2 studies. Headache. 2020;60(10):2202-2219.
Seng EK, Singer AB, Metts C, et al. Does mindfulness-based cognitive therapy for migraine reduce migraine-related disability in people with episodic and chronic migraine? A phase 2b pilot randomized clinical trial. Headache. 2019;59(9):1448-1467.
Wells RE, O'Connell N, Pierce CR, et al. Effectiveness of mindfulness meditation vs headache education for adults with migraine: a randomized clinical trial. JAMA Intern Med. 2021;181(3):317-328.
Martin PR, Aiello R, Gilson K, Meadows G, Milgrom J, Reece J. Cognitive behavior therapy for comorbid migraine and/or tension-type headache and major depressive disorder: an exploratory randomized controlled trial. Behav Res Ther. 2015;73:8-18.
Dindo L, Recober A, Marchman JN, Turvey C, O'Hara MW. One-day behavioral treatment for patients with comorbid depression and migraine: a pilot study. Behav Res Ther. 2012;50(9):537-543.
Brietzke E, Kauer-Sant'anna M, Jackowski A, et al. Impact of childhood stress on psychopathology. Braz J Psychiatry. 2012;34:480-488.
Elsayed NM, Fields KM, Olvera RL, Williamson DE. The role of familial risk, parental psychopathology, and stress for first-onset depression during adolescence. J Affect Disord. 2019;253:232-239.
Olatunji BO, Wolitzky-Taylor KB. Anxiety sensitivity and the anxiety disorders: a meta-analytic review and synthesis. Psychol Bull. 2009;135(6):974-999.
Vaessen T, van Nierop M, Decoster J, et al. Is sensitivity to daily stress predictive of onset or persistence of psychopathology? Eur Psychiatry. 2017;45:167-173.
Vlaeyen JWS, Linton SJ. Fear-Avoidance and its Consequences in Chronic Musculoskeletal Pain: A State of the Art. Elsevier B.V.; 2000.
Boersma K, Linton SJ. How does persistent pain develop? An analysis of the relationship between psychological variables, pain and function across stages of chronicity. Behav Res Ther. 2005;43:1495-1507.
Norton PJ, Asmundson GJG. Anxiety sensitivity, fear, and avoidance behavior in headache pain. Pain. 2004;111(1):218-223.
Martin PR, Reece J, Callan M, et al. Behavioral management of the triggers of recurrent headache: a randomized controlled trial. Behav Res Ther. 2014;61:1-11.
Martin PR, Reece J, MacKenzie S, Bandarian-Balooch S, Brunelli A, Goadsby PJ. Integrating headache trigger management strategies into cognitive-behavioral therapy: a randomized controlled trial. Health Psychol. 2021;40(10):674-685.
Hedman-Lagerlöf M, Hedman-Lagerlöf E, Axelsson E, et al. Internet-delivered exposure therapy for fibromyalgia: a randomized controlled trial. Clin J Pain. 2018;34(6):532-542.
Leistad RB, Sand T, Westgaard RH, Nilsen KB, Stovner LJ. Stress-induced pain and muscle activity in patients with migraine and tension-type headache. Cephalalgia. 2006;26(1):64-73.
Leistad RB, Stovner LJ, White LR, Nilsen KB, Westgaard RH, Sand T. Noradrenaline and cortisol changes in response to low-grade cognitive stress differ in migraine and tension-type headache. J Headache Pain. 2007;8(3):157-166.
Radat F, Creach C, Swendsen J, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005;25:519-522.
Hammond NG, Colman I. The role of positive health behaviors in the relationship between early life stress and migraine. Headache. 2020;60(6):1111-1123.
Tietjen GE, Khubchandani J, Herial NA, Shah K. Adverse childhood experiences are associated with migraine and vascular biomarkers. Headache. 2012;52(6):920-929.
Houle TT, Turner DP, Golding AN, et al. Forecasting individual headache attacks using perceived stress: development of a multivariable prediction model for persons with episodic migraine. Headache. 2017;57(7):1041-1050.